Clinical Trial: A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Tru

Brief Summary: This is a randomized, double-blind, vehicle-controlled, parallel group study of A-101 Solution 40% compared with Vehicle Solution.

Detailed Summary: This is a randomized, double-blind, vehicle-controlled, parallel group study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face. The Target Lesions will be treated, by an investigational staff member other than the evaluating investigator, a maximum of two times.
Sponsor: Aclaris Therapeutics, Inc.

Current Primary Outcome: Lesion clearance [ Time Frame: Day 106 of the study ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Percent of lesion clearance [ Time Frame: Day 106 of the study ]

Original Secondary Outcome: Same as current

Information By: Aclaris Therapeutics, Inc.

Dates:
Date Received: January 26, 2016
Date Started: January 2016
Date Completion:
Last Updated: December 1, 2016
Last Verified: December 2016